Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 1, 2015
Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fractionNicolas F Schroten, Kevin Damman, Mattia A E Valente, et al.
Kidney & Blood Pressure Research|December 14, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatmentMireille E Emans, Branko Braam, Adry Diepenbroek, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trialSimon D Roger, Carlo A Gaillard, Andreas H Bock, et al.
Plos One|June 9, 2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD TrialCarlo A Gaillard, Andreas H Bock, Fernando Carrera, et al.
Plos One|September 8, 2012
Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failureKim E Jie, Karien van der Putten, Sebastiaan Wesseling, et al.
Annals of Neurology|February 26, 2003
Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodiesMichiel Coesmans, Peter A Sillevis Smitt, David J Linden, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 2015
Estimation of total kidney volume in autosomal dominant polycystic kidney diseaseEdwin M Spithoven, Maatje D A van Gastel, A Lianne Messchendorp, et al.
Plos One|July 19, 2012
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agentsNeelke C van der Weerd, Muriel P C Grooteman, Michiel L Bots, et al.
Pageof 2